Latest MediSapiens Ltd. Stories
HELSINKI, May 13, 2014 /PRNewswire/ -- MediSapiens Ltd, a Finnish company developing bioinformatics applications for the pharmaceutical industry, today announced that it
HELSINKI, June 1, 2010 /PRNewswire/ -- MediSapiens, world's first software company for personalized cancer medicine in oncology clinics and drug development, completed $ 1 million (EUR 0.8 million) seed round investment from Veraventure, ETFIII advised by Eqvitec Partners, VTT Ventures and Lifeline Ventures. MediSapiens is based on scientific research at the VTT Technical Research Centre of Finland and its collaborators.